Valutazione delle esigenze normative – elenco
Valutazione delle esigenze normative – elenco
The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed.
For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.
The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Last updated 29 aprile 2024. Database contains 5009 unique substances/entries.
931-700-2
|
-
|
ECHA
|
Under development
|
CCH CoRAP |
16-nov-2018
|
Details | ||
263-058-8
|
61789-40-0
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
931-296-8
|
97862-59-4
|
ECHA
|
Under development
|
RMOA
|
16-nov-2018
|
Details | ||
308-107-7
|
97862-59-4
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
931-333-8
|
-
|
ECHA
|
Under development
|
RMOA
|
16-nov-2018
|
Details | ||
947-523-9
|
-
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
931-513-6
|
-
|
ECHA
|
Under development
|
RMOA
|
16-nov-2018
|
Details | ||
946-191-2
|
-
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
224-292-6
|
4292-10-8
|
ECHA
|
Under development
|
RMOA
|
16-nov-2018
|
Details | ||
211-748-4
|
693-33-4
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
211-669-5
|
683-10-3
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
220-006-9
|
2601-33-4
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
480-680-7
|
-
|
ECHA
|
Under development
|
No action
|
16-nov-2018
|
Details | ||
204-126-9
|
116-14-3
|
Ireland
|
Carcinogenic |
Concluded
|
CLH
|
31-ott-2018
|
Details | |
200-679-5
|
68-12-2
|
Commission
|
Toxic for reproduction |
Concluded
|
Restriction
|
25-ott-2018
|
Details | |
204-826-4
|
127-19-5
|
Commission
|
Toxic for reproduction |
Concluded
|
Restriction
|
25-ott-2018
|
Details | |
212-828-1
|
872-50-4
|
Commission
|
Toxic for reproduction |
Concluded
|
Restriction
|
25-ott-2018
|
Details | |
610-589-1
|
50926-11-9
|
Netherlands
|
Other environmental toxicity Other human toxicity Toxic for reproduction |
Concluded
|
Other
|
13-ott-2018
|
Details | |
260-830-6
|
57583-54-7
|
France
|
Endocrine disruption |
Concluded
|
Other
|
10-ago-2018
|
Details | |
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC / List no:
-
| CAS no:
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC / List no:
-
| CAS no:
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EC / List no:
236-948-9
| CAS no:
13560-89-9
|
-
|
-
|
United Kingdom
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
10-ago-2018
|
Details |
202-924-1
|
101-20-2
|
France
|
Endocrine disruption |
Concluded
|
Other
|
09-ago-2018
|
Details | |
232-565-6
|
9000-90-2
|
United Kingdom
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Other
|
17-lug-2018
|
Details | |
221-967-7
|
3296-90-0
|
Norway
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
SVHC
|
03-lug-2018
|
Details | |
208-762-8
|
540-97-6
|
United Kingdom
|
Bioaccumulation Consumer use Exposure Persistence Widespread use |
Concluded
|
SVHC Restriction |
13-giu-2018
|
Details | |
203-585-2
|
108-46-3
|
Finland
|
Endocrine disruption |
Concluded
|
CLH
|
17-mag-2018
|
Details | |
AP-5
|
401-720-1
|
6807-17-6
|
Sweden
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
SVHC
|
17-mag-2018
|
Details |
show/hide
Potassium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonate
EC / List no:
249-616-3
| CAS no:
29420-49-3
Ammonium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonate
EC / List no:
269-513-7
| CAS no:
68259-10-9
1-(4-butoxy-1-naphthyl)tetrahydrothiophenium nonafluorobutane-1-sulfonate
EC / List no:
468-770-4
| CAS no:
-
N,N,N-triethylethanaminium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
EC / List no:
700-536-1
| CAS no:
25628-08-4
bis(4-tert-butylphenyl)iodonium nonafluorobutane-1-sulfonate
EC / List no:
432-660-4
| CAS no:
194999-85-4
|
799-977-0
|
-
|
Norway
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC Restriction |
12-mar-2018
|
Details |
205-861-8
|
156-62-7
|
ECHA
|
Other human toxicity STOT RE Toxic for reproduction |
Concluded
|
CLH Restriction |
12-mar-2018
|
Details | |
231-106-7
|
7439-97-6
|
Sweden
|
Other human toxicity STOT RE Toxic for reproduction |
Concluded
|
None
|
09-feb-2018
|
Details | |
223-861-6
|
4098-71-9
|
Sweden
|
Exposure Mutagenic Skin sensitiser |
Concluded
|
None
|
09-feb-2018
|
Details | |
209-136-7
|
556-67-2
|
Germany
|
Aggregated tonnage Bioaccumulation Exposure Other environmental toxicity Persistence |
Concluded
|
SVHC
|
12-gen-2018
|
Details | |
234-541-0
|
12008-41-2
|
Sweden
|
Toxic for reproduction |
Concluded
|
SVHC
|
05-gen-2018
|
Details | |
208-764-9
|
541-02-6
|
Germany
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
05-gen-2018
|
Details | |
272-489-0
|
68855-54-9
|
Netherlands
|
Other environmental toxicity Other human toxicity Persistence Toxic for reproduction |
Concluded
|
Other legislation
|
15-dic-2017
|
Details | |
255-288-2
|
41272-40-6
|
Netherlands
|
Skin sensitiser |
Concluded
|
CLH
|
15-dic-2017
|
Details | |
show/hide
|
-
|
-
|
Germany
|
Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction |
Concluded
|
Restriction
|
07-dic-2017
|
Details |
206-196-6
|
307-24-4
|
Germany
|
Other environmental toxicity |
Concluded
|
SVHC
|
07-dic-2017
|
Details | |
262-967-7
|
61788-32-7
|
Finland
|
Aggregated tonnage Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
09-nov-2017
|
Details | |
201-581-5
|
85-01-8
|
France
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
13-ott-2017
|
Details | |
231-100-4
|
7439-92-1
|
Sweden
|
Other environmental toxicity Other human toxicity Toxic for reproduction |
Concluded
|
SVHC
|
13-ott-2017
|
Details | |
207-995-2
|
504-60-9
|
Netherlands
|
Other environmental toxicity Other human toxicity |
Concluded
|
Other legislation
|
15-ago-2017
|
Details | |
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77377.
|
269-047-4
|
68186-85-6
|
Netherlands
|
Other environmental toxicity Other human toxicity Toxic for reproduction |
Concluded
|
None
|
15-ago-2017
|
Details |
201-245-8
|
80-05-7
|
Germany
|
Aggregated tonnage Endocrine disruption Widespread use |
Concluded
|
SVHC
|
15-ago-2017
|
Details | |
201-245-8
|
80-05-7
|
France
|
Endocrine disruption Mutagenic Toxic for reproduction |
Concluded
|
SVHC
|
15-ago-2017
|
Details | |
203-080-7
|
103-11-7
|
Sweden
|
Skin sensitiser |
Concluded
|
None
|
15-ago-2017
|
Details | |
256-032-2
|
42978-66-5
|
Sweden
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
None
|
15-ago-2017
|
Details | |
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
EC / List no:
939-460-0
| CAS no:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
EC / List no:
300-298-5
| CAS no:
93925-00-9
|
-
|
-
|
Austria
|
Endocrine disruption Skin sensitiser |
Concluded
|
SVHC
|
05-lug-2017
|
Details |
204-927-3
|
129-00-0
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
05-lug-2017
|
Details | |
201-581-5
|
85-01-8
|
Germany
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
05-lug-2017
|
Details | |
200-579-1
|
64-18-6
|
Bulgaria
|
Bioaccumulation Endocrine disruption Other human toxicity Persistence |
Concluded
|
None
|
05-lug-2017
|
Details | |